The Epidemiology of COVID-19 Vaccine-Induced Myocarditis

Table 3

Report of the observed number of myocarditis cases in a 7-day risk window after the second dose of mRNA COVID-19 vaccination according to USA VAERS through June 11, 2021.

Age group (years)	Average doses administered	Observed cases
		Females	Males
12–17	2114799	19	128
18–24	4787275	23	219
25–29	3888775	7	59
30–39	8833799	11	61
40–49	9252770	18	34
50–64	17476189	18	18
>65	19875261	10	11